HK Stock Market Move | SIRNAOMICS-B (02257) rose more than 10%, intending to issue 17.3524 million subscription shares at a discount of approximately 19.84%, raising a net total of approximately 206 million Hong Kong dollars.

date
08/09/2025
avatar
GMT Eight
Sanofi-Aventis (02257) rose more than 10%, as of the time of writing, it increased by 10.29%, reaching HK$16.51, with a trading volume of HK$51.769 million.
SIRNAOMICS-B (02257) rose more than 10%, as of the time of writing, up 10.29% to HK$16.51, with a turnover of HK$51.769 million. On the news front, SIRNAOMICS-B announced that on September 7, 2025, the company intends to issue 17.3524 million subscription shares to the subscribers (Bloomage Biotechnology Corporation Limited, Mr. Xie Shuohao, Bamboo Bloom Limited, Capstone Resources Holding Limited), representing approximately 14.16% of the enlarged issued share capital of the company after the issuance. The subscription price is HK$12.00 per subscription share, representing a discount of approximately 19.84% to the closing price of HK$14.97 per share on September 5. The total proceeds from the subscription will be approximately HK$2.082 billion, with net proceeds of approximately HK$2.06 billion. The group intends to use the proceeds from the subscription for its general operating funds.